Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 24
119
Views
1
CrossRef citations to date
0
Altmetric
Short Communications

Evaluation of the anticonvulsant and antioxidant activity of alkylated cardanol in rodents

, , , , , & show all
Pages 6168-6174 | Received 27 Jul 2020, Accepted 13 Sep 2020, Published online: 04 Nov 2020
 

Abstract

The present study aims to evaluate the anticonvulsant and antioxidant activity of the alkylated cardanol in mice, as well as the possible mechanisms involved. Albino mice were used. The pentylenetetrazol, picrotoxin, and pilocarpine were used to induce seizures clonic. The effect of selective receptor antagonist GABAA on anticonvulsant activity was investigated with flumazenil. The antioxidant activity was evaluated by the formation of lipid peroxides, nitrite content, and concentration of reduced glutathione. The largest dose of alkylated cardanol increased the latency of the first seizure induced by pentylenetetrazol acting on the GABAergic receptors. The treatment did not alter body weight and did not cause death in animals. It was observed a reduction in locomotor activity and motor coordination. Treatment reduced the level of lipid peroxidation and contents of nitrite and increased levels of GSH in the hippocampus and frontal cortex. Alkylated cardanol showed a protective effect against convulsions induced in mice.

Graphical abstarct

Acknowledgments

The authors would like to thank the Experimental Neurochemistry [LAPNEX] and the Federal University of Piauí for financial support.

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.